Bone resorption and bone formation takes place continuously in the body and is a balanced process, but when there is imbalance in this process the bones get dissolved by the osteoclasts and start losing calcium. This eventually leads to osteoporosis and other conditions like hypercalcemia as the calcium mixed in the blood. Bisphosphonates prevent bone damage and are used for bone strengthening and hardening. Bisphosphonates are group of drugs having high affinity for the bone tissue and are widely used for treatment of bone related diseases like osteoporosis, myeloma and bone metastasis. With the rising incidence rate of myeloma and geriatric population the Bisphosphonates market is expected to show healthy growth during the forecast period.
The Bisphosphonates market is mainly driven by the incidence and prevalence rate of bone diseases. The expansion in geriatric population is the major driver for the bisphosphonates market. Ageing people start losing bone density and may suffer from fractures therefore bisphosphonate treatment becomes necessary for such patients. According to the U.S. Department of Health and Human Services, 2013 survey, nearly 14.1% of the U.S. population was aged above 65 years and is increasing rapidly. Another significant factor favorable for the growth of bisphosphonates market is the escalation in the number of women in the post-menopausal stage, who suffer from the weakening bones. The total number of women attaining menopause is estimated to cross 1 bn. by 2025, according to the International Menopause Society the number of menopausal women is higher in the developing. Incidence rate of cancers like myeloma which cause loss of bone density. Bisphosphonates are also used for therapy in the patients suffering from breast cancer and prostate cancer. However bisphosphonate treatment has some restraints, bisphosphonates cause some side-effects like upset stomach and inflammation, erosion of esophagus and arterial fibrillation among some women. This along with the presence of alternative therapies may hinder the growth of the bisphosphonates market.
The Global bisphosphonates market is segmented on the basis of route of administration, therapeutic areas and region
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1619
Segmentation based on mode of delivery
Segmentation based on therapeutic areas
- Breast Cancer
- Prostate Cancer
- Degenerative bone diseases
Segmentation by Application
Segmentation by Distribution Channel
- Retail Pharmacies
- Online Pharmacies
With the increasing geriatric population and bone related injuries the overall market for bisphosphonates is increasing very rapidly. Moreover significant increase in the healthcare spending will boost the bisphosphonates market during the forecast period.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1619
Geographically the bisphosphonates market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region.
North America and Europe are currently leading in the bisphosphonates market due to high per capita healthcare spending and high incidence of myeloma in this regions. APAC is expected to show the highest growth rate in the bisphosphonate market due to the high prevalence and incidence of osteoporosis cases and large number of post-menopausal women. APAC region will show tremendous growth in the bisphosphonates market during the forecast period followed by Latin America mainly due to the increased healthcare spending by the governments for the development of health of women. MEA will also follow up with Latin America owing to the suitable demographics required for the growth of the bisphosphonates market.
Some major companies in the bisphosphonates market are Merck, Sanofi-Aventis, Roche, Novartis, Proctor & Gamble and Pfizer